Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy, a

Press/Media

Period4 Jun 2018

Media coverage

1

Media coverage

  • TitleLandmark TAILORx Results, Published Today in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy, a
    Media name/outletPlus Company Updates (PCU)
    Country/TerritoryUnited States
    Date4/06/18
    PersonsJoseph Sparano